Apple and OpenEvidence have launched an experimental artificial intelligence-powered health chat application as part of a study examining how people interact with conversational healthcare technology. The partnership was announced on November 15, 2026, during the HLTH conference in Las Vegas. The study aims to evaluate how consumers use AI health chatbots, particularly in areas such as trust, understanding and the quality of responses. Sumbul Desai, Apple's vice president of Health and Fitness, said the company wanted to work with a clinically grounded partner to investigate how people engage with conversational AI for health-related information. She highlighted scientific rigour as a key motivation behind the research, explaining that the study would examine what builds user trust, how users interpret AI-generated responses and the overall quality of the information provided. OpenEvidence is Apple's partner in the initiative, bringing its focus on clinically grounded AI-powered health information to the experimental project. An important aspect of the application is its ability to connect with users' personal data, allowing the system to use relevant health information when generating responses. This could help researchers understand whether access to individual health information changes the usefulness and relevance of AI-generated answers.The initiative reflects growing interest in combining artificial intelligence with personal health information. However, the application is experimental, and the announcement describes a research study rather than a general public product launch. The findings could offer insights into how conversational AI tools can support access to health information while addressing concerns about reliability and user trust.

AdvertisementThe Puranic